p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis (Q42827384)

8 November 2017

title

p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis (English)

1 reference

8 November 2017

1 reference

H Y Yang

1

1 reference

8 November 2017

R Shao

series ordinal

2

1 reference

8 November 2017

M C Hung

series ordinal

3

1 reference

8 November 2017

M H Lee

series ordinal

4

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

8 November 2017

1 reference

8 November 2017

volume

20

1 reference

8 November 2017

issue

28

1 reference

8 November 2017

page(s)

3695-3702

1 reference

New insights into the tumor suppression function of P27(kip1)

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

The murine gene p27Kip1 is haplo-insufficient for tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

HER-2/neu-targeting gene therapy-a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

Correlation of p27 protein expression with HER-2/neu expression in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204472

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1204472

1 reference

Dimensions Publication ID

8 November 2017

1014472834

0 references

1 reference